Free Trial

SeaStar Medical (ICU) Competitors

SeaStar Medical logo
$0.71 +0.04 (+6.74%)
Closing price 04:00 PM Eastern
Extended Trading
$0.68 -0.03 (-4.18%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ICU vs. FEMY, NXGL, RVP, NRXS, ALUR, PETV, CLGN, NXL, IRIX, and XAIR

Should you be buying SeaStar Medical stock or one of its competitors? The main competitors of SeaStar Medical include Femasys (FEMY), NexGel (NXGL), Retractable Technologies (RVP), NeurAxis (NRXS), Allurion Technologies (ALUR), PetVivo (PETV), CollPlant Biotechnologies (CLGN), Nexalin Technology (NXL), IRIDEX (IRIX), and Beyond Air (XAIR). These companies are all part of the "medical equipment" industry.

SeaStar Medical vs. Its Competitors

SeaStar Medical (NASDAQ:ICU) and Femasys (NASDAQ:FEMY) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, profitability, dividends, valuation and analyst recommendations.

Femasys has a consensus price target of $8.67, indicating a potential upside of 884.85%. Given Femasys' stronger consensus rating and higher possible upside, analysts clearly believe Femasys is more favorable than SeaStar Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SeaStar Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Femasys
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

1.7% of SeaStar Medical shares are owned by institutional investors. Comparatively, 65.3% of Femasys shares are owned by institutional investors. 1.3% of SeaStar Medical shares are owned by company insiders. Comparatively, 11.5% of Femasys shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Femasys has higher revenue and earnings than SeaStar Medical. Femasys is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SeaStar Medical$140K56.78-$24.83M-$3.47-0.20
Femasys$1.63M17.56-$18.82M-$0.91-0.97

SeaStar Medical has a net margin of 0.00% compared to Femasys' net margin of -1,242.06%. SeaStar Medical's return on equity of 0.00% beat Femasys' return on equity.

Company Net Margins Return on Equity Return on Assets
SeaStar MedicalN/A N/A -313.28%
Femasys -1,242.06%-392.45%-137.15%

In the previous week, SeaStar Medical had 3 more articles in the media than Femasys. MarketBeat recorded 4 mentions for SeaStar Medical and 1 mentions for Femasys. Femasys' average media sentiment score of 0.93 beat SeaStar Medical's score of 0.39 indicating that Femasys is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SeaStar Medical
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Femasys
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

SeaStar Medical has a beta of -1.09, indicating that its share price is 209% less volatile than the S&P 500. Comparatively, Femasys has a beta of -2.56, indicating that its share price is 356% less volatile than the S&P 500.

Summary

Femasys beats SeaStar Medical on 10 of the 16 factors compared between the two stocks.

Get SeaStar Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ICU and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ICU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ICU vs. The Competition

MetricSeaStar MedicalMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$7.45M$6.98B$5.54B$9.41B
Dividend YieldN/A2.88%3.75%4.03%
P/E Ratio-0.2018.0921.0120.09
Price / Sales56.7836.65433.8199.01
Price / CashN/A28.0836.1658.27
Price / Book-2.099.018.125.65
Net Income-$24.83M$233.10M$3.25B$257.91M
7 Day Performance19.96%-0.15%0.97%2.09%
1 Month Performance-27.58%1.22%7.36%11.13%
1 Year Performance-90.25%23.83%31.31%18.40%

SeaStar Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ICU
SeaStar Medical
0.4788 of 5 stars
$0.71
+6.7%
N/A-91.4%$7.45M$140K-0.202
FEMY
Femasys
2.9033 of 5 stars
$0.93
-0.2%
$8.67
+832.6%
-18.5%$23.80M$1.70M-1.0230
NXGL
NexGel
0.7265 of 5 stars
$2.64
-0.4%
N/A+13.3%$20.28M$8.69M-5.8710News Coverage
Gap Up
RVP
Retractable Technologies
1.6943 of 5 stars
$0.66
+1.2%
N/A-42.0%$19.69M$33.75M-1.22240Positive News
Gap Up
NRXS
NeurAxis
3.3032 of 5 stars
$2.70
+4.7%
$7.00
+159.3%
-5.9%$19.48M$2.93M-1.4719
ALUR
Allurion Technologies
3.3204 of 5 stars
$2.57
+2.4%
$22.83
+788.5%
-87.3%$18.72M$32.11M-0.21501
PETV
PetVivo
N/A$0.75
-3.8%
N/A+42.1%$18.21M$1.05M-1.6720
CLGN
CollPlant Biotechnologies
2.42 of 5 stars
$1.35
-2.4%
$11.50
+751.9%
-63.7%$17.60M$510K-1.1170Gap Up
NXL
Nexalin Technology
3.0353 of 5 stars
$0.95
-1.1%
$5.00
+426.3%
-14.8%$16.49M$131.07K-1.143Positive News
IRIX
IRIDEX
1.0868 of 5 stars
$0.95
+2.2%
N/A-36.5%$15.61M$48.67M-2.21120Positive News
XAIR
Beyond Air
4.6283 of 5 stars
$0.19
+6.0%
$1.50
+690.3%
-71.1%$15.46M$3.70M-0.2470Analyst Forecast

Related Companies and Tools


This page (NASDAQ:ICU) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners